✦ LIBER ✦

P.17.8 CLINICAL FEATURES, THERAPEUTIC OUTCOME AND PREDICTOR OF RESPONSE IN HCV GENOTYPE 1A AND 1B: SIMILARITIES AND DIFFERENCES

✍ Scribed by Morisco, F.; Di Marco, V.; Caporaso, N.; Granata, R.; Camera, S.; Ippolito, A.; Margaglione, M.; Fattovich, G.; Smedile, A.; Clery, E.; Ferraiuoli, C.; Cossiga, V.; Guarino, M.; Donnarumma, L.; Valvano, M.R.; Milella, M.; Felder, M.M.; Gaeta, G.B.; Gatti, P.; Tundo, P.; Barone, M.; Cozzolongo, R.; Angelico, M.; Mazzella, G.; Santantonio, T.; Andriulli, A.

Book ID: 122247111
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 91 KB
Volume: 46
Category: Article
ISSN: 1590-8658
DOI: 10.1016/S1590-8658(14)60363-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HCV genotype 1a and 1b: Similarities and

HCV genotype 1a and 1b: Similarities and differences in clinical features, therapeutic outcome and predictors of response

✍ Morisco, F.; Di Marco, V.; Caporaso, N.; Granata, R.; Camera, S.; Ippolito, A.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P729 HCV GENOTYPE 1A AND 1B: SIMILARITIE

P729 HCV GENOTYPE 1A AND 1B: SIMILARITIES AND DIFFERENCES IN CLINICAL FEATURES, THERAPEUTIC OUTCOME AND PREDICTORS OF RESPONSE

✍ Morisco, F.; Di Marco, V.; Granata, R.; Camera, S.; Ippolito, A.; Margaglione, M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 74 KB

HCV genotype 1 subtypes (1a and 1b): sim

HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome

✍ Andriulli, A.; Morisco, F.; Ippolito, A. M.; Di Marco, V.; Valvano, M. R.; Angel 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 347 KB

P.201 Identification of a duplication of

P.201 Identification of a duplication of the V3 domain in the NS5A region in HCV genotype 1b infected patients: prevalence and relation with clinical outcome in two cohorts

✍ H. Le Guillou-Guillemette; O. Petsaris; C. Payan; P. Veillon; C. Gaudy; S. Alain 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A matched case-controlled study of 48 an

A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response

✍ Norio Akuta; Fumitaka Suzuki; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract Substitution of amino acid (aa) 70 and 91 in the core region of HCV genotype 1b is a useful pretreatment predictor of efficacy of 48‐week peginterferon (PEG‐IFN) plus ribavirin (RBV) therapy. Here, we determined the efficacy of 72‐week PEG‐IFN/RBV and the predictive factors to such ther

AID FOR MOROCCAN PARALYSIS VICTIMS: HALF

AID FOR MOROCCAN PARALYSIS VICTIMS: HALF-YEARLY REPORT1 1Miss Dunsford's report to the Red Cross Society, covering the period January to June, 1960, and dealing with her experience at Sidi Slimane, is published, slightly condensed, by kind permission of the Australian Red Cross Society. For further information on the causation of this tragic epidemic, the clinical features and the general background, the reader is referred to THE AUSTRALIAN JOURNAL OF PHYSIOTHERAPY, 1960, 6: 33 and 85, and to the article by Miss Beatrice Burke (p 8), who served in a different area.

✍ Dunsford, Frances 📂 Article 📅 1961 🏛 Australian Physiotherapy Association 🌐 English ⚖ 503 KB